SGO 2018: A Vaccine Shows Promise Against Ovarian Cancer
March 26, 2018 9:11 pmA vaccine derived from a patient’s tumor cells, which enhances T-cell targeting of cancer cells, has shown promise against ovarian cancer.
This outcome of a phase 1 clinical trial was reported at the Society of Gynecologic Oncology’s 2018 Annual Meeting … Read more